Am J Transplant, Volume 22, Suppl 3 Archives - Page 17 of 190 - ATC Abstracts

2022 American Transplant Congress
Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help?
A. Kwong¹, W. Kim¹, D. Schladt², A. Wey², J. Snyder², A. Israni², J. Lake³
¹Stanford University, Stanford, CA, ²Hennepin Healthcare Research Institute, Minneapolis, MN, ³University of Minnesota, Minneapolis, MN
*Purpose: In the United States, priority on the liver transplant waitlist is determined by the model for end-stage liver disease (MELD)-Na, a score composed of…
2022 American Transplant Congress
Immune Checkpoints, Immune Cells, and MHC Expression in the Tumor Microenvironment of Resected Hepatocellular Carcinomas
A. Baquerizo¹, V. Vavinskaya², S. Bagsic¹, A. Rojas³, A. Mhoyan⁴, C. Frenette¹, L. Sher⁵, M. Romero³, J. Fisher¹, C. Marsch¹, R. Schaffer¹
¹Scripps, La Jolla, CA, ²UCSD, San Diego, CA, ³University, Seville, Spain, ⁴Kaiser, San Diego, CA, ⁵USC, Los Angeles, CA
*Purpose: Advances in tumor biology has shown the important role of the tumor microenvironment (TME) in tumor growth and metastasis. A better understanding of the…
2022 American Transplant Congress
Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation
K. Genena, D. Milliner, J. Lieske
Nephrology and Hypertension, Mayo Clinic, Rochester, MN
*Purpose: To demonstrate the role of simultaneous liver kidney transplant in PH2*Methods: A 30-year-old white man presented to our center for evaluation of chronic kidney…
2022 American Transplant Congress
Heart-Kidney Transplantation Appears to Be Acceptable for Patients Greater Than 65 Years of Age
T. Singer-Englar, M. Kittleson, J. Patel, N. Patel, S. Kim, D. Chang, E. Kransdorf, L. Czer, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Heart-kidney transplantation (HKTx) has been found to improve survival in patients with advanced kidney disease who undergo heart transplantation. It is not known whether…
2022 American Transplant Congress
Factors Contributing To SARS-CoV-2 Vaccine Hesitancy In Kidney Transplant Candidates
P. LaBella¹, E. Silverman², S. Mehta³, N. M. Ali⁴
¹Transplant Infectious Disease, New York University Langone Health, New York, NY, ²Transplant Infectious Disease, New York University Grossman School of Medicine, New York, NY, ³New York University Langone Transplant Institute, New York, NY, ⁴Transplant Institute, NYU Langone Health, New York, NY
*Purpose: SARS-CoV-2 infection in kidney transplant recipients is associated with an increased risk of severe disease and mortality relative to other patient populations, with mortality…
2022 American Transplant Congress
ROImax Score: A Novel Predictor for Adherent Perinephric Fat in Healthy Donor for Transplantation Underwent Laparoscopic Donor Nephrectomy
T. Noda, Y. Miyauchi, K. Nishimura, T. Fukumoto, N. Miura, T. Kikugawa, T. Saika
Ehime University Graduate School of Medicine, Toon City, Japan
*Purpose: MAP (Mayo adhesive probability) score have been known as a predictor of adherent perinephric fat (APF) in partial nephrectomy. This study is aimed to…
2022 American Transplant Congress
Racial/Ethnic Disparities in Rates of Living Donor Liver Transplant Are Partly Explained by Socioeconomic Deprivation in Adults
S. Frey, T. Ishaque, C. Qin, A. Cameron, A. Massie, D. Segev, E. King
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Living donor liver transplant (LDLT) is an important strategy for addressing the deceased donor liver shortage and is associated with improved survival but represents…
2022 American Transplant Congress
Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: An Analysis of the European Liver Transplant Registry
M. P. Claasen¹, T. Ivanics², J. N. IJzermans¹, G. Sapisochin², W. Polak¹
¹HPB and Transplant Surgery, Erasmus MC, Rotterdam, Netherlands, ²Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada
*Purpose: Little is known about combined hepatocellular-cholangiocarcinoma (cHCC-CCA) demographics and their long-term outcomes after liver transplantation (LT). By analysing data from the European Liver Transplant…
2022 American Transplant Congress
Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series
R. Pearson¹, J. Wubetu¹, K. Stevenson¹, E. Aitken¹, A. Jackson¹, M. Clancy², D. B. Kingsmore¹
¹Renal Transplant, Queen Elizabeth University Hospital, Glasgow, Glasgow, United Kingdom, ²Renal Transplantation, Queen Elizabeth University Hospital, Glasgow, United Kingdom
*Purpose: Ex vivo normothermic perfusion (EVNP) is increasingly recognized as a viability tool to increase organ utilization. We report use of EVNP to assess graft…
2022 American Transplant Congress
Equity in Access to Deceased Donor Transplant for Candidates on the Heart Waitlist
K. Bradbrook¹, A. Robinson¹, R. Goff¹, D. Stewart²
¹Research, United Network for Organ Sharing, Richmond, VA, ²United Network for Organ Sharing, Richmond, VA
*Purpose: Transplantation is often the gold standard therapy for those with organ failure, but limited supply prevents all patients from accessing this treatment. The Organ…